PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
03-Jul-2024 Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication Pneumagen
03-Jul-2024 Agreement to Explore Optimer Vehicles for Targeted Delivery of siRNA Aptamer Group plc
03-Jul-2024 Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing Syncona Limited
02-Jul-2024 Almirall launches Act4Impact – its updated sustainability strategy setting ambitious targets for 2030 Almirall
02-Jul-2024 Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout Sob
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics
02-Jul-2024 ramarketing strengthens AI capabilities with key leadership appointments ramarketing
02-Jul-2024 Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma Biotherapeutics, Inc.
01-Jul-2024 Veranova Announces New Investment to Expand ADC and Highly Potent API Capabilities at Devens, MA, Facility Veranova
01-Jul-2024 Biora Therapeutics Announces Positive Clinical Trial Results for BT-600 Biora Therapeutics
01-Jul-2024 Carthera receives positive opinion from French High Authority for Health on Innovation Funding scheme to treat patients with recurrent glioblastoma Andrew Lloyd Associates
28-Jun-2024 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma AB
28-Jun-2024 Almirall’s Ilumetri® (tildrakizumab) restores and maintains wellbeing of patients with moderate-to-severe plaque psoriasis to the levels of the general population for up to 1 year[i] Almirall
28-Jun-2024 Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution ArisGlobal
28-Jun-2024 Creative Proteomics Launches Disulfide Bond Analysis Service Creative Proteomics
28-Jun-2024 Creative Proteomics Elevates Protein Research with Innovative Crosslinking Protein Interaction Analysis Service Creative Proteomics
28-Jun-2024 Proregulations Announces Participation in 29th CBA Annual Conference Proregulations
28-Jun-2024 Creative Enzymes Introduces Fermented Calcium Propionate for Superior Food Preservation Solutions Creative Enzymes
28-Jun-2024 Creative Enzymes Pioneers Enzyme Discovery for Industry Advancement Creative Enzymes
27-Jun-2024 NICE recommends CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) as the first single infusion gene therapy for adults with severe or moderately severe haemophilia B without a history of FIX inhibitors for reimbursement via a managed access agreement, recognising the treatment as cost-effective in England. CSL Behring